ATR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.654000E-01
Normal-vs-Stage2
5.198600E-01
Normal-vs-Stage3
1.514390E-01
Normal-vs-Stage4
6.751800E-01
Stage1-vs-Stage2
3.165400E-01
Stage1-vs-Stage3
3.088200E-02
Stage1-vs-Stage4
9.819400E-01
Stage2-vs-Stage3
5.015500E-02
Stage2-vs-Stage4
3.974000E-01
Stage3-vs-Stage4
1.026370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.025400E-01
Normal-vs-AfricanAmerican
6.807600E-01
Normal-vs-Asian
4.294200E-01
Caucasian-vs-AfricanAmerican
2.230800E-01
Caucasian-vs-Asian
4.102800E-01
AfricanAmerican-vs-Asian
2.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.879000E-01
Normal-vs-Female
5.264400E-01
Male-vs-Female
4.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.629800E-01
Normal-vs-Age(41-60Yrs)
5.901000E-01
Normal-vs-Age(61-80Yrs)
4.614800E-01
Normal-vs-Age(81-100Yrs)
3.108200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.941800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.632400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.753200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.392100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.541800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.803000E-01
Normal-vs-Daily Drinker
4.156200E-01
Normal-vs-Weekly Drinker
1.386970E-01
Normal-vs-Occasional Drinker
5.750400E-01
Normal-vs-Social Drinker
3.224000E-01
Non Drinker-vs-Daily Drinker
4.598000E-01
Non Drinker-vs-Weekly Drinker
6.937400E-01
Non Drinker-vs-Occasional Drinker
4.014800E-01
Non Drinker-vs-Social Drinker
3.713800E-01
Daily Drinker-vs-Weekly Drinker
8.132400E-01
Daily Drinker-vs-Occasional Drinker
1.652800E-01
Daily Drinker-vs-Social Drinker
1.669950E-01
Weekly Drinker-vs-Occasional Drinker
3.014200E-01
Weekly Drinker-vs-Social Drinker
2.946400E-01
Occasional Drinker-vs-Social Drinker
9.107000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.455800E-02
Normal-vs-Grade 2
3.817000E-03
Normal-vs-Grade 3
3.559500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.487590E-02
Grade 1-vs-Grade 3
1.664410E-02
Grade 1-vs-Grade 4
8.455800E-02
Grade 2-vs-Grade 3
6.855400E-01
Grade 2-vs-Grade 4
3.817000E-03
Grade 3-vs-Grade 4
3.559500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.160000E-01
Normal-vs-NonDiabetic
4.857000E-01
Diabetic-vs-NonDiabetic
1.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.023000E-01
Normal-vs-NoPancreatitis
4.601000E-01
Pancreatitis-vs-NoPancreatitis
3.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.847200E-01
Normal-vs-N1
5.158800E-01
N0-vs-N1
5.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.771800E-01
Normal-vs-TP53-NonMutant
5.809200E-01
TP53-Mutant-vs-TP53-NonMutant
2.646000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
